KE Spotlight - Community Engagement - HKU Knowledge Exchange

HKU and the Servier Research Group Join Hands to Develop a New Line of Pharmaceutical Products in the field of Osteogenesis

The University of Hong Kong has collaborated with the Servier Research Group, the second largest French pharmaceutical company, on the research and development of drugs for osteogenesis.

Learn about Childhood Rheumatic Diseases

Many people think rheumatism will only attack the elderly, while in fact it is a common illness found in children. Our Department of Paediatrics and Adolescent Medicine has launched a new book of the series entitled ‘Childhood Rheumatic Diseases 3 - The Paediatric Diseases You Must Learn', which explores the very common chronic childhood rheumatic diseases through the experience of three patients and their parents.

HKU Successfully Developed Oral Arsenic Trioxide as the First Ever Patented Prescription Drug in Hong Kong: A Success Story of Hong Kong Innovation

A research team at our Department of Medicine and the Queen Marry Hospital has spent a decade developing oral arsenic trioxide from a research project to a prescription medication that has secured a US patent. For the first time, a drug developed entirely in Hong Kong is poised to attain global status as a prescription medication.